Related Experiment Videos
Critical importance of citrate--blood ratio in platelet aggregation studies
Insights
High citrate concentrations significantly inhibit platelet aggregation induced by adenosine diphosphate, epinephrine, and collagen. Controlling the citrate-to-blood ratio is crucial for accurate platelet function tests.
Area of Science:
- Hematology
- Clinical Pathology
Background:
- Platelet aggregation is a critical hemostatic process.
- Citrate is a common anticoagulant used in blood collection.
- Accurate assessment of platelet function is vital for diagnosing bleeding disorders and evaluating antiplatelet therapies.
Purpose of the Study:
- To investigate the impact of varying citrate concentrations on human platelet aggregation.
- To determine the differential effects of citrate on platelet aggregation induced by various agonists.
Main Methods:
- Human platelet-rich plasma was prepared from blood anticoagulated with different citrate concentrations.
- Platelet aggregation was measured using adenosine diphosphate, epinephrine, collagen, and ristocetin as agonists.
- The degree of inhibition of platelet aggregation was quantified at each citrate concentration.
Main Results:
- Small increases in citrate concentration significantly inhibited platelet aggregation induced by adenosine diphosphate, epinephrine, and collagen.
- Epinephrine-induced aggregation showed the greatest inhibition, while collagen-induced aggregation showed the least.
- Ristocetin-induced platelet aggregation remained unaffected by excess citrate anticoagulation.
Conclusions:
- Citrate concentration critically influences the results of platelet aggregation assays.
- The citrate-to-blood ratio must be carefully controlled in clinical settings for reliable platelet function testing.
- These findings have implications for the accurate assessment of antiplatelet drug efficacy.
Abstract:
The effects of citrate concentration on adenosinediphosphate-, epinephrine-, collagen-, and ristocetin-induced human platelet aggregation were investigated. Relatively small increments in citrate concentration markedly inhibited platelet aggregation by all three physiologic agents. The inhibitory effect was greatest on epinephrine-induced aggregation, and least on collagen-induced aggregation. Ristocetin-induced aggregation was not affected by excess citrate anticoagulation. These findings indicate the importance of controlling the citrate:blood ratio in clinical platelet aggregation studies and in the assessment of antiplatelet drugs.